Drugs / Hypertonic Saline Solution
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06442280 | Jun 2024 → Jan 2026 | symptomatic heart failure, type 2 diabetes mellitus | University of Palermo | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypertonic Saline Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06442280 ↗ |
| Route | Intravenous | “Intravenous infusion of furosemide combined with hypertonic saline solutions (100 mL) twice daily” NCT06442280 ↗ |